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Abstract
Background: Dementia is one of the most disabling and burdensome diseases. Incontinence in people with dementia is
distressing, adds to carer burden, and influences decisions to relocate people to care homes. Successful and safe
management of incontinence in people with dementia presents additional challenges. The aim of this study was to
investigate the rates of first diagnosis in primary care of urinary and faecal incontinence among people aged 60–89 with
dementia, and the use of medication or indwelling catheters for urinary incontinence.
Methods and Findings: We extracted data on 54,816 people aged 60–89 with dementia and an age-gender stratified
sample of 205,795 people without dementia from 2001 to 2010 from The Health Improvement Network (THIN), a United
Kingdom primary care database. THIN includes data on patients and primary care consultations but does not identify care
home residents. Rate ratios were adjusted for age, sex, and co-morbidity using multilevel Poisson regression. The rates of
first diagnosis per 1,000 person-years at risk (95% confidence interval) for urinary incontinence in the dementia cohort,
among men and women, respectively, were 42.3 (40.9–43.8) and 33.5 (32.6–34.5). In the non-dementia cohort, the rates
were 19.8 (19.4–20.3) and 18.6 (18.2–18.9). The rates of first diagnosis for faecal incontinence in the dementia cohort were
11.1 (10.4–11.9) and 10.1 (9.6–10.6). In the non-dementia cohort, the rates were 3.1 (2.9–3.3) and 3.6 (3.5–3.8). The adjusted
rate ratio for first diagnosis of urinary incontinence was 3.2 (2.7–3.7) in men and 2.7 (2.3–3.2) in women, and for faecal
incontinence was 6.0 (5.1–7.0) in men and 4.5 (3.8–5.2) in women. The adjusted rate ratio for pharmacological treatment of
urinary incontinence was 2.2 (1.4–3.7) for both genders, and for indwelling urinary catheters was 1.6 (1.3–1.9) in men and 2.3
(1.9–2.8) in women.
Conclusions: Compared with those without a dementia diagnosis, those with a dementia diagnosis have approximately
three times the rate of diagnosis of urinary incontinence, and more than four times the rate of faecal incontinence, in UK
primary care. The clinical management of urinary incontinence in people with dementia with medication and particularly
the increased use of catheters is concerning and requires further investigation.
Please see later in the article for the Editors’ Summary.
Citation: Grant RL, Drennan VM, Rait G, Petersen I, Iliffe S (2013) First Diagnosis and Management of Incontinence in Older People with and without Dementia in
Primary Care: A Cohort Study Using The Health Improvement Network Primary Care Database. PLoS Med 10(8): e1001505. doi:10.1371/journal.pmed.1001505
Academic Editor: Martin J. Prince, King’s College London, United Kingdom
Received March 22, 2013; Accepted July 19, 2013; Published August 27, 2013
Copyright:  2013 Grant et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors received no specific funding for this analysis of THIN but the resources were made possible through a programme grant from the National
Institute for Health Research.
Competing Interests: SI seeks funding for research projects on the diagnosis and management of dementia syndrome. All other authors have declared that no
competing interests exist.
Abbreviations: NHS, National Health Service; PYAR, person-years at risk; THIN, The Health Improvement Network (UK).
* E-mail: robert.grant@sgul.kingston.ac.uk
PLOS Medicine | www.plosmedicine.org 1 August 2013 | Volume 10 | Issue 8 | e1001505
Introduction
Dementia is one of the most disabling and burdensome diseases.
It is increasing in incidence and prevalence worldwide and has a
considerable impact on health and social care systems [1–3].
Incontinence is a significant contributor to the burden of those
providing unpaid care to people with dementia and often triggers
the relocation of people to care homes [4–6]. The clinical syndrome
of dementia includes progressive deterioration in cognition, the
abilities to undertake daily living activities, and physical functioning,
including control of voiding and coping with incontinence [7,8]. In
addition, behavioural and psychological problems can manifest in
socially inappropriate voiding behaviours [9,10]. Health profes-
sionals, service planners, and policy makers in many countries are
seeking ways to support family carers and enable people with
dementia to remain in their own homes [11,12].
There is evidence that older adults delay seeking medical help for
incontinence and that the responses of some health professionals to
incontinence are sub-optimal [13–16]. In addition, older adults are
less likely to receive treatment congruent with evidence-based
guidelines [16–19]. The high prevalence of incontinence in people
with dementia who reside in care homes is well documented [8], but
international estimates suggest that over two-thirds of all people
with dementia live in their own homes [20,21]. Effective planning
and commissioning of services for this population requires data on
the incidence of incontinence among people with dementia living at
home, yet a recent systematic review identified that there were no
published studies that reported the incidence or prevalence of
urinary and/or faecal incontinence in this community-dwelling
population [22]. One recent study in low- and middle-income
countries (China, India, and Latin America) identified an increasing
prevalence of incontinence with dementia severity [1].
This study aimed to investigate the first diagnosis and treatment
of urinary and faecal incontinence in people with dementia living
in the community, by analysing routinely collected data from
general practices in the United Kingdom through The Health
Improvement Network (THIN) [23]. We sought to answer these
questions: (1) What is the rate of first diagnosis of urinary and
faecal incontinence in primary care patients aged 60–89 y with
diagnosis of dementia compared to those without diagnosis of
dementia? (2) In general practice patients aged 60–89 y with a
diagnosis of urinary incontinence, does the presence of a diagnosis
of dementia, compared to no diagnosis of dementia, affect the rate
of first use of (a) pharmacological treatments or (b) indwelling
urinary catheters for urinary incontinence?
Methods
Data Source
We used data from THIN primary care database. This database
comprises routine records of consultations from nearly 500 general
practices, the main providers of primary care within the National
Health Service (NHS) in the United Kingdom. The NHS provides
for universal registration as a patient with a general practice,
including residents in care homes (either residential homes or nursing
homes) [24]. Over 98% of the UK population are registered with a
general practice and THIN has been shown to be representative of
national statistics for general practice patients [25]. THIN contains
coded records for symptoms, diagnoses, investigations, prescriptions,
referrals, demographics, and some neighbourhood characteristics,
including socio-economic deprivation as described by quintiles of
Townsend score (derived from 2001 Census data for unemployment,
overcrowding, car ownership, and home ownership) [26].
Study Population
We selected a dementia cohort identified by the presence of
one or more codes associated with a clear diagnosis of dementia,
or two or more prescriptions for drugs unambiguously intended
to treat dementia (donepezil, galantamine, memantine, rivastig-
mine). Lists of these codes were developed by searching data
dictionaries using the method described by Dave´ and Petersen
and confirmed by two general practitioners (GR and SI) [27]. We
excluded data from the first 4 mo following new registration with
a practice, as this has been shown to contain retrospective
recording of a past history rather than a true incident recording
of a new episode of dementia [28]. Patients in the dementia
cohort were followed up from the latest of the following: their
60th birthday, the day they registered with the practice, the day
of their first dementia code, the day the practice was deemed to
have achieved an acceptable level of data quality [29–31], or 1
January 2001. Patients exited the study on the earliest of the
following: the day they transferred out of the practice, their date
of death, the last date the practice contributed data to THIN, or
31 December 2010. Patients with prevalent incontinence were
not at risk of acquiring it, and so were not eligible for the study.
Patients with less than 6 mo data in the study, those aged 90 y or
over at entry, and those with any codes indicating learning
disabilities or Down syndrome were excluded.
For the non-dementia cohort, we identified a random sample of
up to four times as many people without a record of dementia,
stratified on general practice, 5-y age bands, and sex. In some
practices it was not possible to obtain exactly four times as many
individuals without dementia in the older age bands.
Outcomes and Covariates
Incontinence was defined by the presence of one or more
diagnostic codes for incontinence, or two or more prescriptions for
urinary incontinence (darifenacin, fesoterodine, flavoxate, oxybu-
tynin, propiverine, solifenacin, tolterodine, trospium, and a wide
range of devices specifically for absorption or containment).
Patients identified as having acquired urinary incontinence were
included in analysis for the second research question. The date of
the first prescription of a pharmaceutical treatment was taken as
the endpoint for research question 2(a). For research question 2(b)
on prolonged use of catheters, we sought two or more prescriptions
of indwelling urinary catheters within a 6-mo period and took the
earliest such date as the endpoint.
A measure of treated co-morbidity was taken for each patient by
identifying the number of different drug classes, as defined by the
chapters of the British National Formulary [32], from which they
had received prescribed drugs in the 6 mo preceding the first
incontinence code. For those without incontinence, a 6-mo period
was instead selected at random from the participant’s time
between entering and exiting the study. Drugs relevant to
dementia and incontinence were excluded from this count. For
analysis, the count was categorised into 0, 1–3, 4–6, 7–9, and .9.
We adopted this approach rather than a measure of co-morbidity
such as the Charleson index because prescribed drugs not only
indicate co-morbidity but also influence treatment decisions
through awareness of the risks of polypharmacy [33], and to
capture current conditions more reliably than codes for diagnoses
may allow. A methodological study comparing different co-
morbidity measures in a primary care database of mainly older
people concluded that counts of different drugs or drug classes
were comparable to more formally validated scales in their ability
to predict resource use and serious outcomes [34]. The
categorisation allowed for a non-linear relationship between the
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number of drug classes and the outcomes, in line with similar
findings for co-morbidity [35].
Ethical Review
The NHS South-East Multicentre Research Ethics Committee
approved the scheme for THIN to obtain and provide anonymous
patient data to researchers, and scientific approval for this study
was obtained from THIN Scientific Review Committee in
October 2011 [23].
Statistical Analysis
Rates and rate ratios were calculated for people with and
without dementia. Because the data reflect routine records in
primary care, these rates quantify the first diagnosis of inconti-
nence, and the first treatment, and not the actual onset of disease.
Given the large dataset, approximate 95% confidence intervals
were calculated and the Mantel-Haenszel formula was used to
pool crude rate ratios. Rates were further analysed by multilevel
Poisson regression including the general practice as a random
effect [36]. The impact of dementia was adjusted for sex, age, co-
morbidity, and quintiles of Townsend score by including them as
fixed effects in the regression in that order.
For the second research question about treatments for urinary
incontinence, only people with a record of urinary incontinence
were considered, and the time period after the first such record
was analysed. Multilevel Poisson regression was used to obtain
adjusted rate ratios for the first use of pharmaceutical treatment or
prolonged use of indwelling catheters. All data extraction and
analyses were conducted in Stata software.
Results
Characteristics of the Cohorts
We identified 1,246,963 people from THIN aged 60 to 89 y,
from 487 practices. Of these, 54,816 entered the dementia cohort.
The rate of first diagnosis of dementia rose steadily over that time
from 4.2 per 1,000 person-years at risk (PYAR) in 2001 to 4.9 per
1,000 PYAR in 2010, with a spike in 2006, which was reported
previously [37]. The sampling for the non-dementia cohort
selected 205,795 individuals without incontinence at study entry,
which together with the dementia cohort made a total of
1,228,777 PYAR for analysis in the first research question; five
people were excluded because the endpoint occurred on the day
they entered the study. Urinary incontinence codes were acquired
by 8,987 people (16%) in the dementia cohort and 23,083 in the
non-dementia cohort (11%), and these people’s records were
analysed for the second research question on treatments, making a
total of 92,173 PYAR. The analysis of pharmacological treatments
excluded 7,897 people, and the analysis of catheters excluded 812
people, because the endpoint occurred on the day they entered the
study. Faecal incontinence codes were acquired by 2,909 (5%) and
4,784 (2%), respectively, and double incontinence by 420 (0.7%)
and 240 (0.1%), respectively. Further details of demographics are
shown in Table 1.
Diagnosis of Incontinence
The crude rate of first diagnosis per 1,000 PYAR of any type of
incontinence across both cohorts rose steadily from 19.4 in 2001
to 27.0 in 2010. The rates per 1,000 PYAR (95% CI) for urinary
incontinence in the dementia cohort were 42.3 (40.9–43.8) in
men and 33.5 (32.6–34.5) in women. In the non-dementia cohort,
the rates were 19.8 (19.4–20.3) in men and 18.6 (18.2–18.9) in
women (Figure 1). The rates per 1,000 PYAR for faecal
incontinence in the dementia cohort were 11.1 (10.4–11.9) in
men and 10.1 (9.6–10.6) in women. In the non-dementia cohort,
the rates were 3.1 (2.9–3.3) in men and 3.6 (3.5–3.8) in women.
Among those with records of both dementia and incontinence,
the median time between these records was 9 mo (inter-quartile
range 0–25 mo) in men and 11 mo (inter-quartile range 0–
30 mo) in women.
Table 1. Characteristics of the cohorts.
Characteristics
Category/
Statistic Dementia Cohort (n=54,816) Non-dementia Cohort (n=205,795)
Men (33%,
n=18,187)
Women (67%,
n=36,629)
Men (34%,
n=70,925)
Women (66%,
n=134,870)
Age at entry to study Median (IQR) 78 (72–83) 81 (75–85) 77 (72–82) 80 (75–84)
Years in the study Median (IQR) 4.5 (2.0–8.0) 4.5 (2.1–7.9) 5.3 (2.5–8.8) 5.6 (2.6–9.0)
Months from first dementia code to first
incontinence code
Median (IQR) 9 (0–25) 11 (0–30) N/A N/A
Townsend deprivation 1 (Least deprived) 4,173 (23%) 8,323 (23%) 16,648 (23%) 28,347 (21%)
2 4,169 (23%) 8,212 (22%) 16,031 (23%) 29,587 (22%)
3 3,822 (21%) 7,802 (21%) 14,253 (20%) 28,176 (21%)
4 3,328 (18%) 6,859 (19%) 12,799 (18%) 26,227 (19%)
5 (Most deprived) 2,067 (11%) 4,214 (12%) 8,688 (12%) 17,707 (13%)
Missing 628 (3%) 1,219 (3%) 2,506 (4%) 4,826 (4%)
Co-morbidity index No drugs 1,914 (11%) 3,177 (9%) 9,461 (13%) 15,631 (12%)
1–3 classes 3,859 (21%) 7,885 (22%) 16,959 (24%) 29,503 (22%)
4–6 classes 5,650 (31%) 11,676 (32%) 20,762 (29%) 39,536 (29%)
7–9 classes 4,165 (23%) 8,637 (24%) 14,035 (20%) 29,368 (22%)
10 or more classes 2,599 (14%) 5,254 (14%) 9,708 (14%) 20,832 (15%)
IQR, inter-quartile range; N/A, not applicable.
doi:10.1371/journal.pmed.1001505.t001
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After adjustment for age, sex, and co-morbidity, the rate ratio of
urinary incontinence, comparing those with dementia to those
without, was 3.2 (95% CI 2.7–3.7) in men and 2.7 (2.3–3.2) in
women (Table 2). For faecal incontinence, the adjusted rate ratio
was 6.0 (95% CI 5.1–7.0) in men and 4.5 (3.8–5.2) in women.
Further adjustment by social deprivation did not significantly
improve the regression model of association between dementia
and either form of incontinence.
Association of Dementia Diagnosis with Time to Drug
Treatment for Urinary Incontinence
Drug treatment for urinary incontinence was prescribed in
1,309/8,987 (15%) of the people with dementia and 4,223/23,083
(18%) of those without (Figure 2). The median time from
recording urinary incontinence to drug treatment in months
was: 16 (inter-quartile range 7–31) in men with dementia, 21 (7–
47) in men without dementia, 19 (7–38) in women with dementia,
30 (11–66) in women without dementia.
The stratified rates of first pharmacological treatment are shown
in Figure 2. After adjustment for age, sex, and co-morbidity, the
rate ratio of first pharmacological treatment for urinary inconti-
nence was 2.2 (95% CI 1.4–3.7), comparing those with dementia
to those without, with no significant difference between men and
women (Table 2). This difference between dementia and non-
dementia cohorts was greater in younger age groups: the rate ratio
was 2.2 (95% CI 1.4–3.7) for ages 60–64 compared to 1.1 (1.0–1.3)
for ages 85–89. Further adjustment by social deprivation did not
have an impact on the rate ratios.
Association of Dementia Diagnosis with Use of
Indwelling Urinary Catheters
The rate of first use of prolonged catheterisation was analysed in
12,224 people from the dementia cohort and 34,842 people from
the non-dementia cohort, the other 812 having had prolonged
indwelling urinary catheters prior to entering the cohorts, making
a total of 163,735 PYAR. The median time from incontinence to
prolonged use of indwelling urinary catheters in months was: 18
(inter-quartile range 8–37) in men with dementia, 25 (8–58) in
men without dementia, 26 (11–48) in women with dementia, and
41 (17–79) in women without dementia.
The stratified rates are shown in Figure 3. After adjustment for
age, sex, and co-morbidity, the adjusted rate ratio of prolonged
catheterisation was 1.6 (95% CI 1.3–1.9) in men and 2.3 (1.9–2.8)
in women, comparing those with dementia to those without
(Table 2). The rate rises with age and co-morbidity. The regression
analysis showed that age, sex, and co-morbidity were significant
covariates, along with interactions between co-morbidity and
dementia. Only one of the quintiles of Townsend deprivation
score was significantly different to baseline but without a clear
trend so it was not included as a confounder.
Discussion
To our knowledge, this the first study to report the rate of first
diagnosis of incontinence in primary care in a large community
cohort of people with dementia. The presence of a dementia
diagnosis was associated with an increased rate of first diagnosis of
incontinence in community dwelling people aged 60–89, around
double the rate for urinary incontinence, and triple the rate for
faecal incontinence compared to people without dementia. This
rate ratio, which quantifies the impact of the dementia diagnosis
on incontinence rates, was higher in men and increased with age,
in line with previous research findings [38]. Adjustment for sex
and age led to slightly higher rate ratios and when co-morbidity
was also adjusted for, the rate ratios increased notably. The rate
ratios were greatest for patients who were younger and who had
fewer co-morbidities. This finding reflects the increased risk of
incontinence with age and co-morbidity, even in the absence of
dementia [7].
Figure 1. Rates of first diagnosis of incontinence in men and women with dementia compared to those without. Bars indicate 95%
confidence intervals.
doi:10.1371/journal.pmed.1001505.g001
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The relatively short time from the first recording of dementia to
that of incontinence may reflect the late recording of a diagnosis of
dementia, which has been previously reported [38], when the risk
of incontinence is higher. It may also reflect the known reluctance
to seek medical help for continence problems [14,15]. Family
carers of people with dementia have described in some instances
only seeking help from health professionals about incontinence
problems at the point of crisis [13].
People with dementia and urinary incontinence but no other co-
morbidities received drug treatments at more than double the rate
for people of the same sex, age, and co-morbidity without
dementia. This finding suggests that people with dementia were
being offered drug treatments for their urinary incontinence
earlier and/or in greater numbers than their counterparts without
dementia. This finding requires further investigation to understand
the clinical reasoning. This ratio was notably greater for relatively
younger people with fewer co-morbidities, which may reflect
concerns about drug interactions or polypharmacy that inhibit the
use of this form of treatment in the older age groups.
The rate at which use of indwelling urinary catheters was
initiated was also higher in people with dementia than people
without: 56% greater in men and more than double the rate in
Table 2. Rate ratios, comparing the dementia and non-dementia cohorts.
Outcome Adjusted for Age and Sex (95% CI) Adjusted for Age, Sex and Co-morbidity (95% CI)
First diagnosis of incontinence (any type, including unknown)
(men) 2.15 (2.06–2.24) 3.19 (2.74–3.70)
(women) 1.80 (1.75–1.86) 2.69 (2.32–3.11)
First diagnosis of urinary incontinence
(men) 2.13 (2.04–2.22) 3.17 (2.71–3.71)
(women) 1.81 (1.75–1.87) 2.70 (2.31–3.15)
First diagnosis of faecal incontinence
(men) 3.79 (3.46–4.15) 5.95 (5.06–7.00)
(women) 2.82 (2.64–3.00) 4.48 (3.84–5.21)
First use of pharmacological treatment
(both sexes) 2.16 (1.31–3.55) 2.23 (1.36–3.67)
First use of prolonged indwelling urinary catheterisation
(men) 1.36 (1.24–1.49) 1.56 (1.31–1.86)
(women) 1.98 (1.77–2.21) 2.32 (1.94–2.78)
doi:10.1371/journal.pmed.1001505.t002
Figure 2. Rates of first use of pharmacological treatment for urinary incontinence in men and women with dementia compared to
those without. Bars indicate 95% confidence intervals.
doi:10.1371/journal.pmed.1001505.g002
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women of the same age and co-morbidity. This finding suggests
that an older person with dementia was much more likely to
receive a urinary catheter, and to receive it sooner, than their
counterpart without dementia. Like drug treatment, this
difference was attenuated with increasing co-morbidities al-
though it was not affected by age. Unlike drug treatments, there
is a less powerful clinical rationale for catheterising people with
dementia sooner. Indwelling catheters are associated with
increased risk of infection in older people living in their own
homes and in nursing homes [39–41]. Long term catheter use is
known to be associated with discomfort, meatal tissue damage,
bladder spasm, and formation of bladder calculi [42]. In
addition, the International Continence Society recommends that
cognitive problems are considered as a factor to discourage the
use of indwelling urinary catheters ‘‘through the danger of
interference to the catheter’’ [42]. Given the well-documented
risks associated with indwelling catheters, this finding may
indicate that ease of management is prioritised over risk
avoidance; this requires further investigation.
The strength of this study is the size of the cohorts. We were
able to include 54,816 people with a record of dementia, while
most studies of additional problems and symptoms in people
with dementia have sample sizes in the hundreds [43–45].
There are a number of limitations to this study. Care home
residents are not routinely identified in THIN, which precluded
comparison with individuals resident in their own home [46].
We were unable to investigate surgical treatments for urinary
incontinence as the dataset does not contain all information on
hospital-based care. In the United Kingdom, NHS-funded
absorbent pads are largely supplied through community nursing
services rather than general practices, so we have no informa-
tion on these conservative management strategies. The use of
prescriptions to identify patients with urinary incontinence or
dementia is not validated and so some uncertainty is attached to
it. Because prescriptions for urinary incontinence were used
both to identify patients with incontinence and as an outcome,
the prescription rates may have been slightly inflated. However,
in this study there were no patients identified by dementia drugs
who did not also have diagnostic codes, so these rates would not
have been influenced by this method. Without data from
secondary care and about refusal of referrals, we were unable to
determine how many men received indwelling urinary catheters
because of urinary obstruction where surgery was not appro-
priate.
Dementia and incontinence are both conditions in which
patients delay seeking help from health professionals so the age at
first record in THIN is likely to be greater than the true age at
onset of the condition [14,15]. Finally, the median times between
first diagnosis of dementia and first diagnosis of incontinence (or
incontinence and treatment) are based on those people who were
registered with a general practitioner (GP) and in the cohort
during the whole of the time period of interest. This potentially
underestimates the population medians by excluding those who
acquired dementia or incontinence prior to changing GPs and
hence joining THIN, or before 2001.
Conclusion
The rate of first diagnosis of any type of incontinence is
considerably higher among adults aged 60–89 y with dementia
than among people of the same age and sex distribution without
dementia. Incontinence is a common problem for community-
dwelling people with dementia. Providers and planners of services
for dementia should anticipate high levels of need, including
advice and support for carers managing incontinence. Some
aspects of clinical management of urinary incontinence are
different for patients with dementia compared with those without.
Further study is required to understand the clinical reasoning of
health care practitioners providing care for this population,
particularly in the use of indwelling catheters, given the known
risks.
Figure 3. Rate of first use of prolonged indwelling urinary catheterisation in men and women with dementia compared to those
without. Bars indicate 95% confidence intervals.
doi:10.1371/journal.pmed.1001505.g003
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Editors’ Summary
Background. Globally, more than 35 million people have
dementia, brain disorders that are characterized by an
irreversible decline in cognitive functions such as language
and memory. Alzheimer’s disease and other forms of
dementia mainly affect older people and, because people
are living longer than ever, experts estimate that by 2050
more than 115 million people will have dementia. The
earliest sign of dementia is usually increasing forgetfulness
but, as the disease progresses, people gradually lose their
ability to deal with normal daily activities such as dressing,
they may become anxious or aggressive, and they may lose
control of their bladder (urinary incontinence), bowels
(bowel or fecal incontinence), and other physical functions.
As a result, people with dementia require increasing
amounts of care as the disease progresses. Relatives and
other unpaid carers provide much of this care—two-thirds of
people with dementia are cared for at home. However, many
people with dementia end their days in a care or nursing
home.
Why Was This Study Done? Incontinence in people with
dementia is distressing for the person with dementia and for
their carers and often influences decisions to move individ-
uals into care homes. However, little is known about the
diagnosis and treatment of urinary and/or fecal incontinence
among people with dementia living at home. This informa-
tion is needed to help policymakers commission the services
required for this section of society and insurers recognize the
needs such patients have, as well as helping to raise
clinicians’ awareness of the issue. In this cohort study (an
investigation that compares outcomes in groups of people
with different characteristics), the researchers use data
routinely collected from general practices (primary care) in
the UK to determine the rate of first diagnosis of urinary and
fecal incontinence in elderly patients with and without
dementia and to find out whether a diagnosis of dementia
affects the rate of use of drugs or of indwelling urinary
catheters (tubes inserted into the bladder to drain urine from
the body) for the treatment of urinary incontinence.
What Did the Researchers Do and Find? The researchers
extracted data collected between 2001 and 2010 on
incontinence for nearly 55,000 people aged 60–89 with a
diagnosis of dementia (the dementia cohort) and for more
than 200,000 individuals without a diagnosis of dementia
(the non-dementia cohort) from The Health Improvement
Network (THIN) primary care database, which includes
anonymized consultation records from nearly 500 UK general
practices. In the dementia cohort, the rates of first diagnosis
of urinary incontinence were 42.3 and 33.5 per 1,000 person-
years at risk among men and women, respectively. In the
non-dementia cohort, the corresponding rates were 19.8 and
18.6. The rates of first diagnosis of fecal incontinence were
11.1 and 10.1 in the dementia cohort, and 3.1 and 3.6 in the
non-dementia cohort among men and women, respectively.
After adjusting for age, sex and other diseases, the adjusted
rate ratio for the first diagnosis of urinary incontinence in
people with dementia compared to people without demen-
tia was 3.2 in men and 2.7 in women; for fecal incontinence,
it was 6.0 in men and 4.5 in women; the adjusted rate ratio
was 2.2 for both men and women for drug treatment of
urinary incontinence and 1.6 in men and 2.3 in women for
use of indwelling urinary catheters.
What Do These Findings Mean? These findings indicate
that, in primary care in the UK, dementia is associated with a
three-fold higher rate of diagnosis of urinary incontinence
and a greater than four-fold higher rate of diagnosis of fecal
incontinence. Moreover, the authors suggest that some
aspects of clinical management of urinary continence vary
between people with and without dementia. In particular,
the use of indwelling urinary catheters appears to be more
common among people with dementia than among people
without dementia, increasing the risk of infection. Thus,
health care practitioners providing care for people with
dementia may be prioritizing ease of management over risk
avoidance, a possibility that requires further investigation.
Although the accuracy of these findings is limited by certain
aspects of the study design (for example, the THIN database
does not identify which patients are living in care homes),
they nevertheless suggest that policymakers and insurers
involved in planning and providing services for people with
dementia living at home need to provide high levels of help
with incontinence, including the provision of advice and
support for carers.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001505.
N The UK not-for-profit organization Alzheimer’s Society
provides information for patients and carers about
dementia, including information on coping with
incontinence and personal stories about living with
dementia
N The US not-for-profit organization Alzheimer’s Association
also provides information for patients and carers about
dementia and about incontinence, and personal stories
about dementia
N The UK National Health Service Choices website provides
information (including personal stories) about dementia,
urinary incontinence, and bowel incontinence
N MedlinePlus provides links to further resources about
dementia, urinary incontinence and fecal incontinence (in
English and Spanish)
N The International Continence Society and the International
Consultation on Urological Diseases provide independent
advice on products to manage incontinence
N More information about the THIN database is available
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